{"transactions":[{"id":731626,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks."}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2026-06-18T21:30:28.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":5882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"David Johnson (\"Mr. Johnson\") is deemed to hold the securities reported herein for the benefit of certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan Partners LP (\"Caligan\") serves as investment manager, and may, after vesting, if applicable, transfer the securities directly to such Caligan Funds and Accounts."}],"balance_after":5882,"source":{"system":"sec-edgar","filing":"0000902664-26-002852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266426002852/ownership.xml","form_type":"4"}},{"id":759294,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Option (right to buy)","published_at":"2026-05-29T20:30:16.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted to David Johnson (\"Mr. Johnson\") pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to Mr. Johnson's continuous service through such date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the \"Caligan Master Fund\") and managed accounts to which Caligan Partners LP (\"Caligan\") serves as investment manager (the \"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Master Fund and Accounts\"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Master Fund and Accounts."}],"balance_after":19133,"derivative":{"exercise_price":50.03,"exercise_date":"2026-05-27","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":19133},"source":{"system":"sec-edgar","filing":"0000902664-26-002641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266426002641/ownership.xml","form_type":"4"}},{"id":769530,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T00:51:06.000Z","date":"2026-05-19","kind":"purchase","planned":false,"acquired":true,"shares":5300,"price":59.98,"value":317894.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a transaction between the Caligan Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held by certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan serves as investment manager and related entities. David Johnson (\"Mr. Johnson\", and together with Caligan, the \"Reporting Persons\") is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":8138951,"source":{"system":"sec-edgar","filing":"0000902664-26-002578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266426002578/ownership.xml","form_type":"4"}},{"id":769529,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2026-05-21T00:51:06.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":5300,"price":59.98,"value":317894.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a transaction between the Caligan Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held by certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan serves as investment manager and related entities. David Johnson (\"Mr. Johnson\", and together with Caligan, the \"Reporting Persons\") is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":8133651,"source":{"system":"sec-edgar","filing":"0000902664-26-002578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266426002578/ownership.xml","form_type":"4"}},{"id":987883,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:05:28.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":27532,"price":43.122,"value":1187234.904,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":1553262,"source":{"system":"sec-edgar","filing":"0000902664-25-005164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266425005164/ownership.xml","form_type":"4"}},{"id":1104564,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2025-06-20T20:10:32.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":18396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"David Johnson (\"Mr. Johnson\") is deemed to hold the securities reported herein for the benefit of certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan Partners LP (\"Caligan\") serves as investment manager, and may, after vesting, if applicable, transfer the securities directly to such Caligan Funds and Accounts."}],"balance_after":38755,"source":{"system":"sec-edgar","filing":"0000902664-25-002766","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266425002766/ownership.xml","form_type":"4"}},{"id":1128292,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Option (right to buy)","published_at":"2025-06-02T21:22:46.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":21464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted to David Johnson (\"Mr. Johnson\") pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to Mr. Johnson's continuous service through such date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the \"Caligan Master Fund\") and managed accounts to which Caligan Partners LP (\"Caligan\") serves as investment manager (the \"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Fund and Accounts."}],"balance_after":21464,"derivative":{"exercise_price":42.6,"exercise_date":"2025-05-29","expiration_date":"2032-05-28","underlying":"Common Stock","underlying_shares":21464},"source":{"system":"sec-edgar","filing":"0000902664-25-002613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266425002613/ownership.xml","form_type":"4"}},{"id":1403389,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Notional Derivative Agreements (obligation to buy)","published_at":"2024-09-18T16:30:48.000Z","date":"2024-09-16","kind":"other","planned":false,"acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"As a result of the closing of the merger, the derivative agreements held by the Caligan Funds and Accounts settled in accordance with their terms based on the Merger Consideration."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"As a result of the closing of the merger, the derivative agreements held by the Caligan Funds and Accounts settled in accordance with their terms based on the Merger Consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"As a result of the closing of the merger, the derivative agreements held by the Caligan Funds and Accounts settled in accordance with their terms based on the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"As a result of the closing of the merger, the derivative agreements held by the Caligan Funds and Accounts settled in accordance with their terms based on the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As a result of the closing of the merger, the derivative agreements held by the Caligan Funds and Accounts settled in accordance with their terms based on the Merger Consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities previously held by Caligan Partners Master Fund LP, a Cayman Islands limited partnership, and certain funds and managed accounts to which Caligan serves as investment manager (the \"Caligan Funds and Accounts\"). Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":0,"derivative":{"expiration_date":"2025-09-26","underlying":"Common Stock","underlying_shares":490000},"source":{"system":"sec-edgar","filing":"0000902664-24-005552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266424005552/ownership.xml","form_type":"4"}},{"id":1403388,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2024-09-18T16:30:48.000Z","date":"2024-09-16","kind":"other","planned":false,"acquired":false,"shares":800000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the Effective Time, the warrants to purchase shares of Common Stock were net exercised and the resulting shares of Common Stock were converted into the right to receive the Merger Consideration pursuant to the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, the warrants to purchase shares of Common Stock were net exercised and the resulting shares of Common Stock were converted into the right to receive the Merger Consideration pursuant to the terms of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities previously held by Caligan Partners Master Fund LP, a Cayman Islands limited partnership, and certain funds and managed accounts to which Caligan serves as investment manager (the \"Caligan Funds and Accounts\"). Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":0,"derivative":{"exercise_price":2.1,"exercise_date":"2024-03-24","expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000902664-24-005552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266424005552/ownership.xml","form_type":"4"}},{"id":1403387,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01 per share (\"Common Stock\")","published_at":"2024-09-18T16:30:48.000Z","date":"2024-09-16","kind":"other","planned":false,"acquired":false,"shares":16835154,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024, by and among ANI Pharmaceuticals, Inc., a Delaware corporation (\"ANI\") and Alimera Sciences, Inc., a Delaware corporation (the \"Issuer\") and the other parties thereto (the \"Merger Agreement\") as of the effective time of the merger (the \"Effective Time\"), each outstanding share of Common Stock was cancelled and ceased to exist and converted into the right to receive (i) $5.50 in cash, without interest and (ii) one contingent value right representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between ANI and a rights agent (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024, by and among ANI Pharmaceuticals, Inc., a Delaware corporation (\"ANI\") and Alimera Sciences, Inc., a Delaware corporation (the \"Issuer\") and the other parties thereto (the \"Merger Agreement\") as of the effective time of the merger (the \"Effective Time\"), each outstanding share of Common Stock was cancelled and ceased to exist and converted into the right to receive (i) $5.50 in cash, without interest and (ii) one contingent value right representing the right to receive contingent cash payments subject to the achievement of certain milestones and the terms and conditions set forth in a contingent value rights agreement entered into between ANI and a rights agent (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities previously held by Caligan Partners Master Fund LP, a Cayman Islands limited partnership, and certain funds and managed accounts to which Caligan serves as investment manager (the \"Caligan Funds and Accounts\"). Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000902664-24-005552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266424005552/ownership.xml","form_type":"4"}},{"id":1408327,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2024-09-12T20:31:12.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":1123595,"price":8.9,"value":9999995.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held by certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan Partners LP (\"Caligan\") serves as investment manager and related entities. David Johnson (\"Mr. Johnson\", and together with Caligan, the \"Reporting Persons\") is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":8118592,"source":{"system":"sec-edgar","filing":"0000902664-24-005485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266424005485/ownership.xml","form_type":"4"}},{"id":1415123,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T21:51:34.000Z","date":"2024-08-30","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":9.51,"value":1426500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents a transaction between the Caligan Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan serves as investment manager and related entities. David Johnson (\"Mr. Johnson\", and together with Caligan, the \"Reporting Persons\") is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":6994997,"source":{"system":"sec-edgar","filing":"0000902664-24-005425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266424005425/ownership.xml","form_type":"4"}},{"id":1415122,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T21:51:34.000Z","date":"2024-08-30","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":9.51,"value":1426500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents a transaction between the Caligan Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan serves as investment manager and related entities. David Johnson (\"Mr. Johnson\", and together with Caligan, the \"Reporting Persons\") is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":6844997,"source":{"system":"sec-edgar","filing":"0000902664-24-005425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266424005425/ownership.xml","form_type":"4"}},{"id":1415121,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2024-09-04T21:51:34.000Z","date":"2024-08-30","kind":"other","planned":false,"acquired":false,"shares":3440948,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a pro-rata in-kind distribution by a Caligan Fund (as defined below) to limited partners for no consideration effected as of the close of trading on August 30, 2024. The shares of Common Stock were not disposed of in a sale transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a pro-rata in-kind distribution by a Caligan Fund (as defined below) to limited partners for no consideration effected as of the close of trading on August 30, 2024. The shares of Common Stock were not disposed of in a sale transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of the close of trading on August 30, 2024, a consulting arrangement with a managed account to which Caligan (as defined below) served as a consultant (the \"Consulting Arrangement\") was terminated pursuant to its terms, and accordingly, 845,000 shares of Common Stock which were previously reported by the Reporting Persons (as defined below) that were subject to the Consulting Arrangement are no longer reported herein. The ommon Stock were not disposed of in a sale transaction. 75,000 shares of Common Stock that were previously subject to the Consulting Arrangement were received by Caligan pursuant to amounts due under the terms of the Consulting Arrangement and continue to be reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by certain funds (the \"Caligan Funds\") and managed accounts (the \"Caligan Accounts\", and together with the Caligan Funds, the \"Caligan Funds and Accounts\") to which Caligan serves as investment manager and related entities. David Johnson (\"Mr. Johnson\", and together with Caligan, the \"Reporting Persons\") is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":6994997,"source":{"system":"sec-edgar","filing":"0000902664-24-005425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266424005425/ownership.xml","form_type":"4"}},{"id":1470269,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2024-06-25T01:37:54.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":20359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of certain affiliated funds (the \"Caligan Funds\") to which Caligan Partners LP (\"Caligan\") serves as investment manager and a managed account to which Caligan serves as a consultant, and may, after vesting, if applicable, transfer the securities directly to such Caligan Funds or managed account."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of certain affiliated funds (the \"Caligan Funds\") to which Caligan Partners LP (\"Caligan\") serves as investment manager and a managed account to which Caligan serves as a consultant, and may, after vesting, if applicable, transfer the securities directly to such Caligan Funds or managed account."}],"balance_after":20359,"source":{"system":"sec-edgar","filing":"0001104659-24-074471","document":"tm2418154-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000110465924074471/tm2418154-4_4seq1.xml","form_type":"4"}},{"id":1493554,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks."}}],"security":"Option (right to buy)","published_at":"2024-06-04T21:10:05.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":42767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted to David Johnson (\"Mr. Johnson\") pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to Mr. Johnson's continuous service through such date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the \"Caligan Master Fund\") and managed accounts to which Caligan Partners LP (\"Caligan\") serves as investment manager (the \"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Master Fund and Accounts\"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Master Fund and Accounts."}],"balance_after":42767,"derivative":{"exercise_price":21.69,"exercise_date":"2024-05-31","expiration_date":"2031-05-30","underlying":"Common Stock","underlying_shares":42767},"source":{"system":"sec-edgar","filing":"0000902664-24-004028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266424004028/ownership.xml","form_type":"4"}},{"id":1498398,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-30T23:50:14.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":225000,"price":20.7558,"value":4670055.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased by Caligan Master Fund (as defined below) in multiple transactions at prices ranging from $20.40 to $20.885, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":1525730,"source":{"system":"sec-edgar","filing":"0000902664-24-003949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266424003949/ownership.xml","form_type":"4"}},{"id":1498397,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-30T23:50:14.000Z","date":"2024-05-28","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":20.3195,"value":4063900.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased by Caligan Master Fund (as defined below) in multiple transactions at prices ranging from $20.22 to $20.375, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":1300730,"source":{"system":"sec-edgar","filing":"0000902664-24-003949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266424003949/ownership.xml","form_type":"4"}},{"id":1626549,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-22T22:08:50.000Z","date":"2024-02-21","kind":"purchase","planned":false,"acquired":true,"shares":190000,"price":20.6986,"value":3932734.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased by Caligan Master Fund (as defined below) in multiple transactions at prices ranging from $20.57 to $20.78, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":1100730,"source":{"system":"sec-edgar","filing":"0000902664-24-001966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266424001966/ownership.xml","form_type":"4"}},{"id":1710580,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2023-12-14T21:42:49.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":1117318,"price":7.16,"value":7999996.88,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since the filing of the Form 4 filed by the Reporting Persons on September 7, 2022, and more than 6 months ago, the managed account to which Caligan (as defined below) serves as a consultant has reduced its holding by 480,000 shares of Common Stock, and accordingly, such shares of Common Stock are no longer included in the total amount of securities beneficially owned that are reported in Column 5."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\" and together with Mr. Johnson, the \"Reporting Persons\") with respect to the securities held by (i) Caligan Partners Master Fund LP, a Cayman Islands limited partnership, (ii) an affiliated fund to which Caligan serves as investment manager, (iii) managed accounts to which Caligan serves as investment manager, and (iv) a managed account to which Caligan serves as a consultant. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":11280945,"source":{"system":"sec-edgar","filing":"0000902664-23-005873","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266423005873/ownership.xml","form_type":"4"}},{"id":1728032,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-29T21:30:29.000Z","date":"2023-11-27","kind":"purchase","planned":false,"acquired":true,"shares":120409,"price":21.61,"value":2602038.49,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a rebalancing transaction between the Caligan Fund and Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":910730,"source":{"system":"sec-edgar","filing":"0000902664-23-005732","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266423005732/ownership.xml","form_type":"4"}},{"id":1728031,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-29T21:30:29.000Z","date":"2023-11-27","kind":"sale","planned":false,"acquired":false,"shares":120409,"price":21.61,"value":2602038.49,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a rebalancing transaction between the Caligan Fund and Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":790321,"source":{"system":"sec-edgar","filing":"0000902664-23-005732","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266423005732/ownership.xml","form_type":"4"}},{"id":1779986,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Notional Derivative Agreements (obligation to buy)","published_at":"2023-09-15T16:05:17.000Z","date":"2023-09-14","kind":"other","planned":false,"acquired":true,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents rebalancing transaction between the Caligan Fund and Accounts."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the market close on September 14, 2023, the expiration date of the notional principal amount derivative agreements in the form of cash settled swaps previously reported on the Form 3 filed by the Reporting Persons on August 11, 2023, was extended from February 2, 2024 to September 26, 2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"At the market close on September 14, 2023, the expiration date of the notional principal amount derivative agreements in the form of cash settled swaps previously reported on the Form 3 filed by the Reporting Persons on August 11, 2023, was extended from February 2, 2024 to September 26, 2025."},{"field":"shares","element":"transactionShares","label":"F3","text":"At the market close on September 14, 2023, the expiration date of the notional principal amount derivative agreements in the form of cash settled swaps previously reported on the Form 3 filed by the Reporting Persons on August 11, 2023, was extended from February 2, 2024 to September 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the market close on September 14, 2023, the expiration date of the notional principal amount derivative agreements in the form of cash settled swaps previously reported on the Form 3 filed by the Reporting Persons on August 11, 2023, was extended from February 2, 2024 to September 26, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the market close on September 14, 2023, the expiration date of the notional principal amount derivative agreements in the form of cash settled swaps previously reported on the Form 3 filed by the Reporting Persons on August 11, 2023, was extended from February 2, 2024 to September 26, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the market close on September 14, 2023, the expiration date of the notional principal amount derivative agreements in the form of cash settled swaps previously reported on the Form 3 filed by the Reporting Persons on August 11, 2023, was extended from February 2, 2024 to September 26, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":490000,"derivative":{"underlying":"Common Stock","underlying_shares":490000},"source":{"system":"sec-edgar","filing":"0000902664-23-004790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266423004790/ownership.xml","form_type":"4"}},{"id":1779985,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T16:05:17.000Z","date":"2023-09-14","kind":"purchase","planned":false,"acquired":true,"shares":579000,"price":3.39,"value":1962810.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents rebalancing transaction between the Caligan Fund and Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":16835154,"source":{"system":"sec-edgar","filing":"0000902664-23-004790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266423004790/ownership.xml","form_type":"4"}},{"id":1779984,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value 0.01 per share (Common Stock)","published_at":"2023-09-15T16:05:17.000Z","date":"2023-09-14","kind":"sale","planned":false,"acquired":false,"shares":579000,"price":3.39,"value":1962810.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents rebalancing transaction between the Caligan Fund and Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Fund and Accounts\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":16256154,"source":{"system":"sec-edgar","filing":"0000902664-23-004790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266423004790/ownership.xml","form_type":"4"}},{"id":1803289,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred","published_at":"2023-08-17T19:01:33.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":false,"shares":13431616,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Purchasers\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":0,"derivative":{"exercise_price":1.7,"underlying":"Common Stock","underlying_shares":13431616},"source":{"system":"sec-edgar","filing":"0000902664-23-004504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266423004504/ownership.xml","form_type":"4"}},{"id":1803288,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred","published_at":"2023-08-17T19:01:33.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":false,"shares":2924761,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Purchasers\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":0,"derivative":{"exercise_price":2.1,"underlying":"Common Stock","underlying_shares":2924761},"source":{"system":"sec-edgar","filing":"0000902664-23-004504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266423004504/ownership.xml","form_type":"4"}},{"id":1803287,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T19:01:33.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":true,"shares":13431616,"price":1.7,"value":22833747.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Purchasers\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":16835154,"source":{"system":"sec-edgar","filing":"0000902664-23-004504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266423004504/ownership.xml","form_type":"4"}},{"id":1803286,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01 per share (\"Common Stock\")","published_at":"2023-08-17T19:01:33.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":true,"shares":2924761,"price":2.1,"value":6141998.1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 15, 2023, the Series B Preferred held by the Caligan Purchasers (as defined below) automatically converted to shares of Common Stock pursuant to their terms. The Series B Preferred had no stated maturity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by David Johnson (\"Mr. Johnson\") and Caligan Partners LP (\"Caligan\") with respect to the securities held by Caligan Partners Master Fund LP (\"Caligan Master Fund\"), a Cayman Islands limited partnership, and managed accounts (\"Caligan Accounts\", together with the Caligan Master Fund, the \"Caligan Purchasers\") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":3403538,"source":{"system":"sec-edgar","filing":"0000902664-23-004504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090266423004504/ownership.xml","form_type":"4"}},{"id":1839948,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T21:18:05.000Z","date":"2023-07-03","kind":"other","planned":false,"acquired":false,"shares":670466,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the total number of shares of Common Stock beneficially owned by Caligan Partners LP (\"Caligan\") following the termination of an investment management agreement with respect to an account previously managed by Caligan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction represents an in-kind distribution by certain funds and accounts to which Caligan serves as the investment manager."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This transaction represents an in-kind distribution by certain funds and accounts to which Caligan serves as the investment manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":7797454,"source":{"system":"sec-edgar","filing":"0000902664-23-003816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266423003816/ownership.xml","form_type":"4"}},{"id":1839947,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2023-07-03T21:18:05.000Z","date":"2023-06-29","kind":"other","planned":false,"acquired":false,"shares":108879,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the total number of shares of Common Stock beneficially owned by Caligan Partners LP (\"Caligan\") following the termination of an investment management agreement with respect to an account previously managed by Caligan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":8467920,"source":{"system":"sec-edgar","filing":"0000902664-23-003816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266423003816/ownership.xml","form_type":"4"}},{"id":1847430,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-21T21:22:55.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on June 19, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of certain affiliated funds (the \"Caligan Funds\") to which Caligan Partners LP (\"Caligan\") serves as investment manager and a managed account to which Caligan serves as a consultant, and may, after vesting, if applicable, transfer the securities directly to such Caligan Funds or managed account."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of certain affiliated funds (the \"Caligan Funds\") to which Caligan Partners LP (\"Caligan\") serves as investment manager and a managed account to which Caligan serves as a consultant, and may, after vesting, if applicable, transfer the securities directly to such Caligan Funds or managed account."}],"balance_after":20000,"derivative":{"exercise_price":8.63,"exercise_date":"2026-06-19","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000902664-23-003669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266423003669/ownership.xml","form_type":"4"}},{"id":1870846,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Option (right to buy)","published_at":"2023-06-02T21:06:43.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":36353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date, subject to Mr. Johnson's continuous service through such dates."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the \"Caligan Fund\") and managed accounts to which Caligan Partners LP (\"Caligan\") serves as investment manager (the \"Caligan Accounts\"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Fund and the Caligan Accounts."}],"balance_after":36353,"derivative":{"exercise_price":19.28,"exercise_date":"2023-05-31","expiration_date":"2030-05-30","underlying":"Common Stock","underlying_shares":36353},"source":{"system":"sec-edgar","filing":"0000902664-23-003404","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266423003404/ownership.xml","form_type":"4"}},{"id":1870845,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36677,"kind":"person","name":"Caligan Partners LP","position":2,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:43.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":18176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. (the \"Issuer\") common stock (\"Common Stock\") issued to David Johnson (\"Mr. Johnson\") upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to Mr. Johnson on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on each of the first four anniversaries of the Transaction Date, subject to the Mr. Johnson's continuous service through such dates."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Mr. Johnson is deemed to hold the securities reported herein for the benefit of Caligan Partners Master Fund LP (the \"Caligan Fund\") and managed accounts to which Caligan Partners LP (\"Caligan\") serves as investment manager (the \"Caligan Accounts\"), and may, after vesting, if applicable, transfer the securities directly to the Caligan Fund and the Caligan Accounts."}],"balance_after":18176,"source":{"system":"sec-edgar","filing":"0000902664-23-003404","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000090266423003404/ownership.xml","form_type":"4"}},{"id":2163883,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-09-07T13:15:32.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":250000,"price":5.62,"value":1405000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average purchase price of all purchases by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $5.47 to $5.77."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund to which Caligan serves as investment manager and a managed account to which Caligan serves as a consultant. David Johnson is the Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10643627,"source":{"system":"sec-edgar","filing":"0000902664-22-004182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266422004182/ownership.xml","form_type":"4"}},{"id":2193564,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-05T15:10:58.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":255173,"price":1.75,"value":446552.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average price of all trades by the Reporting Persons on the transaction date for prices ranging from $1.71 to $1.77."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":11444836,"source":{"system":"sec-edgar","filing":"0000902664-22-003823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003823/ownership.xml","form_type":"4"}},{"id":2193563,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-08-05T15:10:58.000Z","date":"2022-08-03","kind":"purchase","acquired":true,"shares":46009,"price":1.74,"value":80055.66,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average price of all trades by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $1.70 to $1.75."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":11189663,"source":{"system":"sec-edgar","filing":"0000902664-22-003823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003823/ownership.xml","form_type":"4"}},{"id":2197979,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T21:27:42.000Z","date":"2022-08-02","kind":"purchase","acquired":true,"shares":272618,"price":1.64,"value":447093.52,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price is the volume weighted average price of all trades by the Reporting Persons on the transaction date for prices ranging from $1.49 to $1.70."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":11143654,"source":{"system":"sec-edgar","filing":"0000902664-22-003778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003778/ownership.xml","form_type":"4"}},{"id":2197978,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T21:27:42.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":210200,"price":1.48,"value":311096.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average price of all trades by the Reporting Persons on the transaction date for prices ranging from $1.40 to $1.52."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10871036,"source":{"system":"sec-edgar","filing":"0000902664-22-003778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003778/ownership.xml","form_type":"4"}},{"id":2197977,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (Common Stock)","published_at":"2022-08-02T21:27:42.000Z","date":"2022-07-29","kind":"purchase","acquired":true,"shares":137648,"price":1.42,"value":195460.16,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average price of all trades by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $1.37 to $1.45."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10660836,"source":{"system":"sec-edgar","filing":"0000902664-22-003778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003778/ownership.xml","form_type":"4"}},{"id":2223683,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-22T20:31:04.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on June 17, 2025."}],"balance_after":20000,"derivative":{"exercise_price":4.86,"exercise_date":"2025-06-17","expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-073526","document":"tm2219055-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785557/000110465922073526/tm2219055-2_4seq1.xml","form_type":"4"}},{"id":2231690,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-06-15T13:06:46.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":100000,"price":1.7,"value":170000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average price of all trades by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $1.64 to $1.75."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10523188,"source":{"system":"sec-edgar","filing":"0000902664-22-003296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003296/ownership.xml","form_type":"4"}},{"id":2242687,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T18:01:27.000Z","date":"2022-06-03","kind":"purchase","acquired":true,"shares":250000,"price":1.98,"value":495000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $1.92 to $2.02."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10423188,"source":{"system":"sec-edgar","filing":"0000902664-22-003177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003177/ownership.xml","form_type":"4"}},{"id":2242686,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-06-06T18:01:27.000Z","date":"2022-06-02","kind":"purchase","acquired":true,"shares":200000,"price":1.92,"value":384000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average selling price of all sales by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $1.83 to $2.00."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10173188,"source":{"system":"sec-edgar","filing":"0000902664-22-003177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422003177/ownership.xml","form_type":"4"}},{"id":2254843,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-05-26T12:47:57.000Z","date":"2022-05-25","kind":"purchase","acquired":true,"shares":79400,"price":3.4,"value":269960.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average purchase price of all purchases by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $3.32 to $3.48."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund to which Caligan serves as investment manager and a managed account to which Caligan serves as a consultant. David Johnson is the Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10393627,"source":{"system":"sec-edgar","filing":"0000902664-22-003105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266422003105/ownership.xml","form_type":"4"}},{"id":2263056,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-19T22:16:33.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":85000,"price":5.81,"value":493850.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price is the volume weighted average purchase price of all purchases by the Reporting Persons on the transaction date for prices ranging from $5.53 to $5.92."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held by an affiliated fund to which Caligan serves as investment manager and a managed account to which Caligan serves as a consultant. David Johnson is the Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10314227,"source":{"system":"sec-edgar","filing":"0000902664-22-003037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266422003037/ownership.xml","form_type":"4"}},{"id":2263055,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-19T22:16:33.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":76404,"price":5.89,"value":450019.56,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average purchase price of all purchases by the Reporting Persons on the transaction date for prices ranging from $5.56 to $6.07."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held by an affiliated fund to which Caligan serves as investment manager and a managed account to which Caligan serves as a consultant. David Johnson is the Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10229227,"source":{"system":"sec-edgar","filing":"0000902664-22-003037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266422003037/ownership.xml","form_type":"4"}},{"id":2263054,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-05-19T22:16:33.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":59700,"price":5.99,"value":357603.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average purchase price of all purchases by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $5.75 to $6.08."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held by an affiliated fund to which Caligan serves as investment manager and a managed account to which Caligan serves as a consultant. David Johnson is the Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10152823,"source":{"system":"sec-edgar","filing":"0000902664-22-003037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266422003037/ownership.xml","form_type":"4"}},{"id":2276427,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T01:03:03.000Z","date":"2022-05-10","kind":"purchase","acquired":true,"shares":25000,"price":2.52,"value":63000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP (\"Caligan\"). David Johnson (together with Caligan, the \"Reporting Persons\") is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price."}],"balance_after":9973188,"source":{"system":"sec-edgar","filing":"0000902664-22-002849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002849/ownership.xml","form_type":"4"}},{"id":2276426,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (Common Stock)","published_at":"2022-05-11T01:03:03.000Z","date":"2022-05-06","kind":"purchase","acquired":true,"shares":463350,"price":2.9,"value":1343715.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP (\"Caligan\"). David Johnson (together with Caligan, the \"Reporting Persons\") is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price."}],"balance_after":9948188,"source":{"system":"sec-edgar","filing":"0000902664-22-002849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002849/ownership.xml","form_type":"4"}},{"id":2286714,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T23:44:18.000Z","date":"2022-05-02","kind":"purchase","acquired":true,"shares":125000,"price":2.81,"value":351250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $ 2.71 to $2.89."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":9484838,"source":{"system":"sec-edgar","filing":"0000902664-22-002740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002740/ownership.xml","form_type":"4"}},{"id":2286713,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T23:44:18.000Z","date":"2022-04-29","kind":"purchase","acquired":true,"shares":247400,"price":2.66,"value":658084.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $2.57 to $2.70."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":9359838,"source":{"system":"sec-edgar","filing":"0000902664-22-002740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002740/ownership.xml","form_type":"4"}},{"id":2286712,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-05-02T23:44:18.000Z","date":"2022-04-28","kind":"purchase","acquired":true,"shares":27600,"price":2.4,"value":66240.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is the volume weighted average selling price of all sales by Caligan Partners LP (\"Caligan\") and David Johnson (together with Caligan, the \"Reporting Persons\") on the transaction date for prices ranging from $2.37 to $2.44."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":9112438,"source":{"system":"sec-edgar","filing":"0000902664-22-002740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002740/ownership.xml","form_type":"4"}},{"id":2295522,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.001 par value per share","published_at":"2022-04-18T22:29:42.000Z","date":"2022-04-18","kind":"purchase","acquired":true,"shares":1764705,"price":5.1,"value":8999995.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by an affiliated fund to which Caligan Partners LP (\"Caligan\") serves as investment manager and a managed account to which Caligan serves as a consultant. David Johnson is the Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":10093123,"source":{"system":"sec-edgar","filing":"0000902664-22-002594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727492/000090266422002594/ownership.xml","form_type":"4"}},{"id":2297904,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-13T20:27:39.000Z","date":"2022-04-12","kind":"purchase","acquired":true,"shares":50000,"price":3.6,"value":180000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP (\"Caligan\"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":9084838,"source":{"system":"sec-edgar","filing":"0000902664-22-002542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002542/ownership.xml","form_type":"4"}},{"id":2297903,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-04-13T20:27:39.000Z","date":"2022-04-11","kind":"purchase","acquired":true,"shares":145000,"price":3.87,"value":561150.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP (\"Caligan\"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":9034838,"source":{"system":"sec-edgar","filing":"0000902664-22-002542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002542/ownership.xml","form_type":"4"}},{"id":2300530,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:19:34.000Z","date":"2022-04-08","kind":"purchase","acquired":true,"shares":200000,"price":3.76,"value":752000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP (\"Caligan\"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":8889838,"source":{"system":"sec-edgar","filing":"0000902664-22-002486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002486/ownership.xml","form_type":"4"}},{"id":2300529,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:19:34.000Z","date":"2022-04-07","kind":"purchase","acquired":true,"shares":200000,"price":3.88,"value":776000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP (\"Caligan\"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":8689838,"source":{"system":"sec-edgar","filing":"0000902664-22-002486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002486/ownership.xml","form_type":"4"}},{"id":2300528,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36677,"kind":"person","name":"Caligan Partners LP","position":1,"cik":"0001727492","reported_name":"Caligan Partners LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":2,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share (\"Common Stock\")","published_at":"2022-04-08T21:19:34.000Z","date":"2022-04-06","kind":"purchase","acquired":true,"shares":109573,"price":3.6,"value":394462.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP (\"Caligan\"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":8489838,"source":{"system":"sec-edgar","filing":"0000902664-22-002486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000090266422002486/ownership.xml","form_type":"4"}},{"id":2582999,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-01T21:27:17.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on August 20, 2024."}],"balance_after":20000,"derivative":{"exercise_price":2.59,"exercise_date":"2024-08-20","expiration_date":"2031-08-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-112115","document":"tm2126786-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785557/000110465921112115/tm2126786-4_4seq1.xml","form_type":"4"}},{"id":2748186,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-15T12:03:26.000Z","date":"2021-04-13","kind":"grant","acquired":true,"shares":16132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in quarterly installments, with 4,840 shares of Common Stock vesting on June 30, 2021 and 5,646 shares of Common Stock vesting on each of September 30, 2021 and December 31, 2021."}],"balance_after":16132,"derivative":{"exercise_price":2.52,"expiration_date":"2031-04-13","underlying":"Common Stock","underlying_shares":16132},"source":{"system":"sec-edgar","filing":"0000902664-21-002335","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785557/000090266421002335/ownership.xml","form_type":"4"}},{"id":2748185,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-15T12:03:26.000Z","date":"2021-04-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 36 equal monthly installments, becoming fully vested on April 13, 2024."}],"balance_after":30000,"derivative":{"exercise_price":2.52,"expiration_date":"2031-04-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000902664-21-002335","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785557/000090266421002335/ownership.xml","form_type":"4"}},{"id":2978827,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:47:02.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":21289,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21289},"source":{"system":"sec-edgar","filing":"0001104659-20-126330","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126330/a4.xml","form_type":"4"}},{"id":2978826,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:47:02.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":9452,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9452},"source":{"system":"sec-edgar","filing":"0001104659-20-126330","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126330/a4.xml","form_type":"4"}},{"id":2978825,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:47:02.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001104659-20-126330","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126330/a4.xml","form_type":"4"}},{"id":2978824,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T15:47:02.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":3499428,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a.r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a.r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Such securities are held by an affiliated fund and managed account to which Caligan Partners LP (\"Caligan\") serves as investment manager. David Johnson is the Partner of Caligan and Managing Member of Caligan Partners GP LLC, the general partner of Caligan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-126330","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126330/a4.xml","form_type":"4"}},{"id":2978823,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T15:47:02.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":14676,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a.r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Each Company RSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a.r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Each Company RSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-126330","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126330/a4.xml","form_type":"4"}},{"id":3122745,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-04T17:25:48.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":21289,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments commencing July 1, 2020."}],"balance_after":21289,"derivative":{"exercise_price":8.52,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":21289},"source":{"system":"sec-edgar","filing":"0000902664-20-002288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000090266420002288/ownership.xml","form_type":"4"}},{"id":3122744,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01 per share (\"Common Stock\")","published_at":"2020-06-04T17:25:48.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":10269,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\") that will vest in twelve equal monthly installments beginning on July 1, 2020; however, delivery of the shares is deferred until the earlier of (a) a Change in Control (as defined in the Issuer's Non-Employee Directors' Deferred Compensation Program) of the Issuer and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":14676,"source":{"system":"sec-edgar","filing":"0000902664-20-002288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000090266420002288/ownership.xml","form_type":"4"}},{"id":3394932,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-10T18:11:54.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":9452,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in seven equal monthly installments commencing November 1, 2019."}],"balance_after":9452,"derivative":{"exercise_price":11.58,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":9452},"source":{"system":"sec-edgar","filing":"0000902664-19-003962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/792977/000090266419003962/ownership.xml","form_type":"4"}},{"id":3394931,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-10T18:11:54.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant."}],"balance_after":6000,"derivative":{"exercise_price":11.58,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000902664-19-003962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000090266419003962/ownership.xml","form_type":"4"}},{"id":3394930,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":36676,"kind":"person","name":"JOHNSON DAVID EDWARD","position":1,"cik":"0001785557","reported_name":"JOHNSON DAVID EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.01 per share (\"Common Stock\")","published_at":"2019-10-10T18:11:54.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":4407,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\") that will vest in seven equal monthly installments beginning on November 1, 2019; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":4407,"source":{"system":"sec-edgar","filing":"0000902664-19-003962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000090266419003962/ownership.xml","form_type":"4"}}]}